Edsberg Laura E, Wyffels Jennifer T, Ogrin Rajna, Craven B Catharine, Houghton Pamela
J Spinal Cord Med. 2015 Jul;38(4):456-67. doi: 10.1179/2045772314Y.0000000212. Epub 2014 Jun 26.
To determine whether the biochemistry of chronic pressure ulcers differs between patients with and without chronic spinal cord injury (SCI) through measurement and comparison of the concentration of wound fluid inflammatory mediators, growth factors, cytokines, acute phase proteins, and proteases.
Survey.
Tertiary spinal cord rehabilitation center and skilled nursing facilities.
Twenty-nine subjects with SCI and nine subjects without SCI (>18 years) with at least one chronic pressure ulcer Stage II, III, or IV were enrolled.
Total protein and 22 target analyte concentrations including inflammatory mediators, growth factors, cytokines, acute phase proteins, and proteases were quantified in the wound fluid and blood serum samples. Blood samples were tested for complete blood count, albumin, hemoglobin A1c, total iron binding capacity, iron, percent (%) saturation, C-reactive protein, and erythrocyte sedimentation rate.
Wound fluid concentrations were significantly different between subjects with SCI and subjects without SCI for total protein concentration and nine analytes, MMP-9, S100A12, S100A8, S100A9, FGF2, IL-1b, TIMP-1, TIMP-2, and TGF-b1. Subjects without SCI had higher values for all significantly different analytes measured in wound fluid except FGF2, TGF-b1, and wound fluid total protein. Subject-matched circulating levels of analytes and the standardized local concentration of the same proteins in the wound fluid were weakly or not correlated.
The biochemical profile of chronic pressure ulcers is different between SCI and non-SCI populations. These differences should be considered when selecting treatment options. Systemic blood serum properties may not represent the local wound environment.
通过测量和比较伤口液中炎症介质、生长因子、细胞因子、急性期蛋白和蛋白酶的浓度,确定慢性脊髓损伤(SCI)患者和非慢性脊髓损伤患者慢性压疮的生物化学特征是否存在差异。
调查。
三级脊髓康复中心和专业护理机构。
招募了29名患有SCI的受试者和9名没有SCI(年龄>18岁)且至少有一处II期、III期或IV期慢性压疮的受试者。
对伤口液和血清样本中的总蛋白以及包括炎症介质、生长因子、细胞因子、急性期蛋白和蛋白酶在内的22种目标分析物浓度进行定量。对血样进行全血细胞计数、白蛋白、糖化血红蛋白A1c、总铁结合力、铁、饱和度百分比(%)、C反应蛋白和红细胞沉降率检测。
SCI患者和非SCI患者的伤口液总蛋白浓度以及9种分析物(基质金属蛋白酶-9、S100A12、S100A8、S100A9、成纤维细胞生长因子2、白细胞介素-1β、金属蛋白酶组织抑制因子-1、金属蛋白酶组织抑制因子-2和转化生长因子-β1)浓度存在显著差异。除成纤维细胞生长因子2、转化生长因子-β1和伤口液总蛋白外,非SCI患者伤口液中所有显著不同分析物的值均较高。分析物的受试者匹配循环水平与伤口液中相同蛋白质的标准化局部浓度之间相关性较弱或无相关性。
慢性压疮的生物化学特征在SCI人群和非SCI人群中存在差异。在选择治疗方案时应考虑这些差异。全身血清特性可能无法代表局部伤口环境。